An experimental drug could help improve movement for patients with spinal cord injuries, and it's already making a big ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.
ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) ...
Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.
Hosted on MSN
FDA clears InterVene’s in-stent restenosis catheter
It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results